Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small-cell lung cancer.

ABSTRACT:

SUBMITTER: Rudin CM 

PROVIDER: S-EPMC3634121 | biostudies-literature | 2013 May

REPOSITORIES: biostudies-literature